4TEEN4 Pharmaceuticals Funding: $94M Raised, Series C (2025)
4TEEN4 Pharmaceuticals is based in Hennigsdorf, Germany. It has raised $94M in total funding. Latest round: Series C.
4TEEN4 Pharmaceuticals funding overview
4TEEN4 Pharmaceuticals is based in Hennigsdorf, Germany. 4TEEN4 Pharmaceuticals has raised $94M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2025. The round record for 4TEEN4 Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include Brandenburg Capital, Wellington Partners Venture Capital, HBM Partners. 3 distinct backers are named across the disclosed rounds.
Frequently asked about 4TEEN4 Pharmaceuticals funding
How much has 4TEEN4 Pharmaceuticals raised?
4TEEN4 Pharmaceuticals has raised $94M in total disclosed funding across the rounds on record.
Who has invested in 4TEEN4 Pharmaceuticals?
Brandenburg Capital, Wellington Partners Venture Capital, HBM Partners are named among the investors backing 4TEEN4 Pharmaceuticals.
What was the latest 4TEEN4 Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in November 2025.
Where is 4TEEN4 Pharmaceuticals based?
4TEEN4 Pharmaceuticals is based in Hennigsdorf, Germany.
When did 4TEEN4 Pharmaceuticals last raise?
The last disclosed 4TEEN4 Pharmaceuticals round closed in November 2025 at Series C.
We update the 4TEEN4 Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hennigsdorf and their backers are listed below.
